Cargando…

A mutation in mannose‐phosphate‐dolichol utilization defect 1 reveals clinical symptoms of congenital disorders of glycosylation type I and dystroglycanopathy

Congenital disorders of glycosylation type I (CDG‐I) are inborn errors of metabolism, generally characterized by multisystem clinical manifestations, including developmental delay, hepatopathy, hypotonia, and skin, skeletal, and neurological abnormalities. Among others, dolichol‐phosphate‐mannose (D...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Tol, Walinka, Ashikov, Angel, Korsch, Eckhard, Abu Bakar, Nurulamin, Willemsen, Michèl A., Thiel, Christian, Lefeber, Dirk J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850978/ https://www.ncbi.nlm.nih.gov/pubmed/31741824 http://dx.doi.org/10.1002/jmd2.12060

Ejemplares similares

Clinical glycomics for the diagnosis of congenital disorders of glycosylation
por: Abu Bakar, Nurulamin, et al.
Publicado: (2018)

Genetic defects in dolichol metabolism
por: Buczkowska, Anna, et al.
Publicado: (2014)

From glycosylation disorders to dolichol biosynthesis defects: a new class of metabolic diseases
por: Cantagrel, Vincent, et al.
Publicado: (2011)

Global serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation
por: Heywood, Wendy E., et al.
Publicado: (2016)

From discrete dilated cardiomyopathy to successful cardiac transplantation in congenital disorders of glycosylation due to dolichol kinase deficiency (DK1-CDG)
por: Kapusta, Livia, et al.
Publicado: (2012)

Clinical outcomes in an adult patient with mannose phosphate isomerase-congenital disorder of glycosylation who discontinued mannose therapy
por: Noman, Kinza, et al.
Publicado: (2020)

Mannose treatment improves immune deficiency in mannose phosphate isomerase–congenital disorder of glycosylation: case report and review of literature
por: De Graef, Diederik, et al.
Publicado: (2022)

Synergistic use of glycomics and single‐molecule molecular inversion probes for identification of congenital disorders of glycosylation type‐1
por: Abu Bakar, Nurulamin, et al.
Publicado: (2022)

Flow Cytometry for the Analysis of α-Dystroglycan Glycosylation in Fibroblasts from Patients with Dystroglycanopathies
por: Stevens, Elizabeth, et al.
Publicado: (2013)

SRD5A3 defective congenital disorder of glycosylation: clinical utility gene card
por: Jaeken, Jaak, et al.
Publicado: (2020)

Poly-Saturated Dolichols from Filamentous Fungi Modulate Activity of Dolichol-Dependent Glycosyltransferase and Physical Properties of Membranes
por: Gryz, Elżbieta, et al.
Publicado: (2019)

Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy
por: Kanagawa, Motoi, et al.
Publicado: (2009)

Mannose phosphate isomerase gene mutation leads to a congenital disorder of glycosylation: A rare case report and literature review
por: Lu, Siliang, et al.
Publicado: (2023)

Muscular Dystrophy with Ribitol-Phosphate Deficiency: A Novel Post-Translational Mechanism in Dystroglycanopathy
por: Kanagawa, Motoi, et al.
Publicado: (2017)

Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies
por: Belaya, Katsiaryna, et al.
Publicado: (2015)

N-Linked Glycans Are Assembled on Highly Reduced Dolichol Phosphate Carriers in the Hyperthermophilic Archaea Pyrococcus furiosus
por: Chang, Michelle M., et al.
Publicado: (2015)

Inhibition of Dephosphorylation of Dolichyl Diphosphate Alters the Synthesis of Dolichol and Hinders Protein N-Glycosylation and Morphological Transitions in Candida albicans
por: Janik, Anna, et al.
Publicado: (2019)

A molecular overview of the primary dystroglycanopathies
por: Brancaccio, Andrea
Publicado: (2019)

Quantification of dolichol in the human lens with different types of cataracts
por: Gajjar, Devarshi, et al.
Publicado: (2009)

Clinical diagnostics and therapy monitoring in the congenital disorders of glycosylation
por: Van Scherpenzeel, Monique, et al.
Publicado: (2016)

Congenital disorder of glycosylation caused by starting site-specific variant in syntaxin-5
por: Linders, Peter T. A., et al.
Publicado: (2021)

Dissecting Total Plasma and Protein-Specific Glycosylation Profiles in Congenital Disorders of Glycosylation
por: Hipgrave Ederveen, Agnes L., et al.
Publicado: (2020)

A new patient‐derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α‐dystroglycan
por: Kim, Jihee, et al.
Publicado: (2019)

Hemostatic defects in congenital disorders of glycosylation
por: Pascreau, Tiffany, et al.
Publicado: (2023)

Dolichol-linked oligosaccharide selection by the oligosaccharyltransferase in protist and fungal organisms
por: Kelleher, Daniel J., et al.
Publicado: (2007)

How to find and diagnose a CDG due to defective N-glycosylation
por: Lefeber, Dirk J., et al.
Publicado: (2011)

Metabolomics profiling reveals new aspects of dolichol biosynthesis in Plasmodium falciparum
por: Zimbres, Flavia M., et al.
Publicado: (2020)

Synthesis of Dolichols in Candida albicans Is Co-Regulated with Elongation of Fatty Acids
por: Janik, Anna, et al.
Publicado: (2021)

Divergent contribution of the MVA and MEP pathways to the formation of polyprenols and dolichols in Arabidopsis
por: Lipko, Agata, et al.
Publicado: (2023)

Alteration of membrane barrier in stripped rough microsomes from rat liver on incubation with GTP: its relevance to the stimulation by this nucleotide of the dolichol pathway for protein glycosylation
Publicado: (1983)

Mannose phosphate isomerase deficiency‐congenital disorder of glycosylation (MPI‐CDG) with cerebral venous sinus thrombosis as first and only presenting symptom: A rare but treatable cause of thrombophilia
por: Mühlhausen, Chris, et al.
Publicado: (2020)

B3GALNT2 mutations associated with non-syndromic autosomal recessive intellectual disability reveal a lack of genotype–phenotype associations in the muscular dystrophy-dystroglycanopathies
por: Maroofian, Reza, et al.
Publicado: (2017)

Distinct Flippases Translocate Glycerophospholipids and Oligosaccharide Diphosphate Dolichols across the Endoplasmic Reticulum
por: Sanyal, Sumana, et al.
Publicado: (2008)

Arabidopsis dolichol kinase AtDOK1 is involved in flowering time control
por: Cho, Yueh, et al.
Publicado: (2017)

Sugary Logistics Gone Wrong: Membrane Trafficking and Congenital Disorders of Glycosylation
por: Linders, Peter T. A., et al.
Publicado: (2020)

Prenatal muscle development in a mouse model for the secondary dystroglycanopathies
por: Kim, Jihee, et al.
Publicado: (2016)

Transferrin mutations at the glycosylation site complicate diagnosis of congenital disorders of glycosylation type I
por: Guillard, Mailys, et al.
Publicado: (2011)

Mutations in INPP5K Cause a Form of Congenital Muscular Dystrophy Overlapping Marinesco-Sjögren Syndrome and Dystroglycanopathy
por: Osborn, Daniel P.S., et al.
Publicado: (2017)

A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation
por: Chu, Jaime, et al.
Publicado: (2013)

Neuromelanins of Human Brain Have Soluble and Insoluble Components with Dolichols Attached to the Melanic Structure
por: Engelen, Mireille, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cnfagn37o5tcsceb6ghbvlco80